InnovaRx Innova Health Strategies

F16.983

Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 2 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 3 never code together
F16.9code
Excludes1
  • hallucinogen abuse (F16.1-)F16.1-
  • hallucinogen dependence (F16.2-)F16.2-
F01-F99chapter
Excludes2
  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)R00-R99

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 4
F16code
Includes
  • ecstasy
  • PCP
  • phencyclidine
F01-F99chapter
Includes
  • disorders of psychological development
Index entries leading here 2
  • Disorder (of) — see also Disease
    • perception, due to hallucinogens F16.983
    • posthallucinogen perception F16.983
  • Use (of)
    • hallucinogen NEC F16.90
      • with
        • perception disorder (flashbacks) F16.983
Alongside this code 2 same parent — F16.98
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC55 CMS28HCC137 ESRD21HCC55 ESRD24HCC55

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
F16.98
Block
F10-F19
Siblings
2

Present FY2024–FY2027.